Upgrade to SI Premium - Free Trial

Analysis: Positioning to Benefit within Clovis Oncology, Destination Maternity, MSG Networks, Lindblad Expeditions, NetScout, and ANI Pharmaceuticals — Research Highlights Growth, Revenue, and Conso

October 18, 2018 9:01 AM

NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Clovis Oncology, Inc. (NASDAQ: CLVS), Destination Maternity Corporation (NASDAQ: DEST), MSG Networks Inc. (NYSE: MSGN), Lindblad Expeditions Holdings Inc. (NASDAQ: LIND), NetScout Systems, Inc. (NASDAQ: NTCT), and ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CLVS DOWNLOAD: http://MarketSourceResearch.com/register/?so=CLVS DEST DOWNLOAD: http://MarketSourceResearch.com/register/?so=DEST MSGN DOWNLOAD: http://MarketSourceResearch.com/register/?so=MSGN LIND DOWNLOAD: http://MarketSourceResearch.com/register/?so=LIND NTCT DOWNLOAD: http://MarketSourceResearch.com/register/?so=NTCT ANIP DOWNLOAD: http://MarketSourceResearch.com/register/?so=ANIP

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Clovis Oncology, Inc. (NASDAQ: CLVS), Destination Maternity Corporation (NASDAQ: DEST), MSG Networks Inc. (NYSE: MSGN), Lindblad Expeditions Holdings Inc. (NASDAQ: LIND), NetScout Systems, Inc. (NASDAQ: NTCT), and ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 16th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CLOVIS ONCOLOGY, INC. (CLVS) REPORT OVERVIEW

Clovis Oncology's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Clovis Oncology reported revenue of $23.76MM vs $14.62MM (up 62.50%) and analysts estimated basic earnings per share -$1.94 vs -$3.88. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Clovis Oncology reported revenue of $55.51MM vs $0.08MM (up 71,067.95%) and analysts estimated basic earnings per share -$7.36 vs -$9.07. Analysts expect earnings to be released on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.24. The estimated EPS forecast for the next fiscal year is -$4.57 and is expected to report on February 25th, 2019.

To read the full Clovis Oncology, Inc. (CLVS) report, download it here: http://MarketSourceResearch.com/register/?so=CLVS

-----------------------------------------

DESTINATION MATERNITY CORPORATION (DEST) REPORT OVERVIEW

Destination Maternity's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Destination Maternity reported revenue of $96.40MM vs $98.28MM (down 1.92%) and analysts estimated basic earnings per share -$0.29 vs -$0.20. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Destination Maternity reported revenue of $406.21MM vs $433.70MM (down 6.34%) and analysts estimated basic earnings per share -$1.57 vs -$2.39. Analysts expect earnings to be released on December 6th, 2018. The report will be for the fiscal period ending October 31st, 2018.

To read the full Destination Maternity Corporation (DEST) report, download it here: http://MarketSourceResearch.com/register/?so=DEST

-----------------------------------------

MSG NETWORKS INC. (MSGN) REPORT OVERVIEW

MSG Networks' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, MSG Networks reported revenue of $171.41MM vs $162.88MM (up 5.23%) and analysts estimated basic earnings per share $0.60 vs $0.51 (up 17.65%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, MSG Networks reported revenue of $696.65MM vs $675.35MM (up 3.15%) and analysts estimated basic earnings per share $3.83 vs $2.22 (up 72.52%). Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.54. The estimated EPS forecast for the next fiscal year is $2.70 and is expected to report on August 21st, 2019.

To read the full MSG Networks Inc. (MSGN) report, download it here: http://MarketSourceResearch.com/register/?so=MSGN

-----------------------------------------

LINDBLAD EXPEDITIONS HOLDINGS INC. (LIND) REPORT OVERVIEW

Lindblad Expeditions' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Lindblad Expeditions reported revenue of $69.47MM vs $55.57MM (up 25.02%) and basic earnings per share $0.00 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Lindblad Expeditions reported revenue of $266.50MM vs $242.35MM (up 9.97%) and analysts estimated basic earnings per share -$0.19 vs $0.11. Analysts expect earnings to be released on November 2nd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $0.35 and is expected to report on February 27th, 2019.

To read the full Lindblad Expeditions Holdings Inc. (LIND) report, download it here: http://MarketSourceResearch.com/register/?so=LIND

-----------------------------------------

NETSCOUT SYSTEMS, INC. (NTCT) REPORT OVERVIEW

NetScout's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, NetScout reported revenue of $205.11MM vs $225.76MM (down 9.14%) and analysts estimated basic earnings per share -$0.78 vs -$0.27. For the twelve months ended March 31st, 2018 vs March 31st, 2017, NetScout reported revenue of $986.79MM vs $1,162.11MM (down 15.09%) and analysts estimated basic earnings per share $0.91 vs $0.36 (up 152.78%). Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $1.31 and is expected to report on May 2nd, 2019.

To read the full NetScout Systems, Inc. (NTCT) report, download it here: http://MarketSourceResearch.com/register/?so=NTCT

-----------------------------------------

ANI PHARMACEUTICALS, INC. (ANIP) REPORT OVERVIEW

ANI Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, ANI Pharmaceuticals reported revenue of $47.27MM vs $44.76MM (up 5.59%) and analysts estimated basic earnings per share $0.24 vs $0.23 (up 4.35%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ANI Pharmaceuticals reported revenue of $176.84MM vs $128.62MM (up 37.49%) and analysts estimated basic earnings per share -$0.09 vs $0.34. Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.03. The estimated EPS forecast for the next fiscal year is $5.67 and is expected to report on February 26th, 2019.

To read the full ANI Pharmaceuticals, Inc. (ANIP) report, download it here: http://MarketSourceResearch.com/register/?so=ANIP

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Hugo Moreau, Media Department Office: +1 (704) 343-6361 E-mail: [email protected]

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Source: Market Source Research

Categories

Press Releases

Next Articles